Tag: Organ Transplants

Graft survival comparable for living unrelated donor, living related donor kidney recipients

Approval is for chronic disease after failure of one or more lines of systemic therapy

Average patient would accept kidney today with 6.5 years of expected graft survival to avoid two years of extra wait time for better kidney

Decrease noted in transplants and in waitlist registrations for transplants compared with those expected

Patients with high tacrolimus intrapatient variability had increased risk for de novo donor-specific antibody formation

Poststroke mortality rates similar for Black and White children during first six months, but higher for Black children after six months

Seventy-four percent of 31 uterus recipients had one-year graft survival; 19 of these 23 women had liveborn children

Candidates aged <12 years at the time of transplantation are exempt from testing if they received postnatal infectious disease testing

Achievement being hailed as a major advance in the field of tissue engineering

Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients